Bank Of America Corp Cullinan Oncology, Inc. Transaction History

Bank Of America Corp

  • $1.33 Trillion
  • Q2 2025

A detailed history of Bank Of America Corp transactions in Cullinan Oncology, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 661,285 shares of CGEM stock, worth $4.52 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
661,285
Previous 524,385 26.11%
Holding current value
$4.52 Million
Previous $3.97 Million 25.45%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$7.13 - $9.08 $976,097 - $1.24 Million
136,900 Added 26.11%
661,285 $4.98 Million
Q1 2025

May 15, 2025
BUY
$7.57 - $12.68 $2.79 Million - $4.68 Million
369,115 Added 237.72%
524,385 $3.97 Million
Q4 2024

Feb 14, 2025
SELL
$10.77 - $17.6 $2.74 Million - $4.48 Million
-254,523 Reduced 62.11%
155,270 $1.89 Million
Q3 2024

Nov 14, 2024
SELL
$16.03 - $20.86 $47,320 - $61,578
-2,952 Reduced 0.72%
409,793 $6.86 Million
Q2 2024

Aug 14, 2024
BUY
$15.63 - $29.35 $4.4 Million - $8.26 Million
281,396 Added 214.24%
412,745 $7.2 Million
Q1 2024

May 15, 2024
SELL
$10.17 - $19.02 $41,320 - $77,278
-4,063 Reduced 3.0%
131,349 $2.24 Million
Q4 2023

Feb 14, 2024
BUY
$7.89 - $10.23 $912,273 - $1.18 Million
115,624 Added 584.31%
135,412 $1.38 Million
Q2 2023

Aug 14, 2023
SELL
$8.8 - $13.4 $584,434 - $889,934
-66,413 Reduced 77.04%
19,788 $212,000
Q1 2023

May 12, 2023
BUY
$10.2 - $11.91 $166,994 - $194,990
16,372 Added 23.45%
86,201 $881,000
Q4 2022

Feb 10, 2023
BUY
$9.72 - $13.62 $67,359 - $94,386
6,930 Added 11.02%
69,829 $736,000
Q3 2022

Nov 14, 2022
BUY
$11.82 - $15.42 $404,563 - $527,780
34,227 Added 119.37%
62,899 $806,000
Q2 2022

Aug 12, 2022
SELL
$7.31 - $13.55 $122,522 - $227,111
-16,761 Reduced 36.89%
28,672 $367,000
Q1 2022

May 16, 2022
BUY
$10.47 - $16.75 $171,540 - $274,432
16,384 Added 56.4%
45,433 $475,000
Q4 2021

Feb 08, 2022
BUY
$15.36 - $25.0 $303,897 - $494,625
19,785 Added 213.57%
29,049 $448,000
Q3 2021

Nov 15, 2021
SELL
$22.56 - $29.68 $121,192 - $159,440
-5,372 Reduced 36.7%
9,264 $209,000
Q2 2021

Sep 13, 2021
BUY
$24.96 - $41.25 $365,314 - $603,735
14,636 New
14,636 $376,000

Others Institutions Holding CGEM

# of Institutions
153
Shares Held
66.5M
Call Options Held
10.6K
Put Options Held
917K
View Full List

About Cullinan Oncology, Inc.

CGEM Quotes by TradingView
  • Ticker CGEM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,612,200
  • Market Cap $312M
  • Description
  • Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...
More about CGEM
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email